Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Oct 29, 2022 1:41am
137 Views
Post# 35057454

RE:RE:RE:RE:From the MD&A...

RE:RE:RE:RE:From the MD&A...Let me explain how this unfolded.

Because I talk to several shareholders, I knew that some were expecting the financials to come out of Friday, which they eventually did.

However, according to the BCSC and the OSC, and according to the filing date formula, Bioasis had until October 31, Monday, to file their Q2 financials.

So, being aware that some shareholders would think that Bioasis would be late if they didn't file on Friday, I posted on Stockhouse and Agoracom that the filing deadline was Monday, October 31.

beenthere, who claims that he doesn't read posts, either didn't read my posts about the deadline, or he was unable to decypher the OSC and BCSC schedules, which are rather difficult to pick apart.

And then along came poof, who said the filings were due on Friday, which they weren't. Bioasis, bless them and all who sail upon her, is usually early by a day or more with its filings, and so they were a business day early this time.

beenthere is a lost soul. He chooses to not read important material, and he can't understand much of what he does read. I don't really want to embarrass him more than that.

jd
<< Previous
Bullboard Posts
Next >>